BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25384882)

  • 1. Prognostic significance of PIK3CA and SOX2 in Asian patients with lung squamous cell carcinoma.
    Iijima Y; Seike M; Noro R; Ibi T; Takeuchi S; Mikami I; Koizumi K; Usuda J; Gemma A
    Int J Oncol; 2015 Feb; 46(2):505-12. PubMed ID: 25384882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease.
    Toschi L; Finocchiaro G; Nguyen TT; Skokan MC; Giordano L; Gianoncelli L; Perrino M; Siracusano L; Di Tommaso L; Infante M; Alloisio M; Roncalli M; Scorsetti M; Jänne PA; Santoro A; Varella-Garcia M
    PLoS One; 2014; 9(4):e95303. PubMed ID: 24736592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations.
    Rekhtman N; Paik PK; Arcila ME; Tafe LJ; Oxnard GR; Moreira AL; Travis WD; Zakowski MF; Kris MG; Ladanyi M
    Clin Cancer Res; 2012 Feb; 18(4):1167-76. PubMed ID: 22228640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer.
    Wilbertz T; Wagner P; Petersen K; Stiedl AC; Scheble VJ; Maier S; Reischl M; Mikut R; Altorki NK; Moch H; Fend F; Staebler A; Bass AJ; Meyerson M; Rubin MA; Soltermann A; Lengerke C; Perner S
    Mod Pathol; 2011 Jul; 24(7):944-53. PubMed ID: 21460799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung.
    Usul Afsar C; Sahin B; Gunaldi M; Kılıc Bagir E; Gumurdulu D; Burgut R; Erkisi M; Kara IO; Paydas S; Karaca F; Ercolak V
    Int J Clin Exp Pathol; 2015; 8(9):9760-71. PubMed ID: 26617686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIK3CA mutations as prognostic factor in squamous cell lung carcinoma.
    McGowan M; Hoven AS; Lund-Iversen M; Solberg S; Helland Å; Hirsch FR; Brustugun OT
    Lung Cancer; 2017 Jan; 103():52-57. PubMed ID: 28024696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer.
    Yang F; Gao Y; Geng J; Qu D; Han Q; Qi J; Chen G
    Int J Clin Exp Pathol; 2013; 6(12):2846-54. PubMed ID: 24294370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of a spectrum of driver genes in female Chinese patients with advanced or metastatic squamous cell carcinoma of the lung.
    Qiong Z; Na WY; Bo W; Zhu Z; Ling P; Bo MH; Min TY; Lei Z; Na HD; Bo Z; Fang LJ; Seng ZS
    Lung Cancer; 2015 Feb; 87(2):117-21. PubMed ID: 25488863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung.
    Chan AW; Chau SL; Tong JH; Chow C; Kwan JSH; Chung LY; Lung RW; Tong CY; Tin EK; Law PP; Law WT; Ng CSH; Wan IYP; Mok TSK; To KF
    J Thorac Oncol; 2019 Jul; 14(7):1213-1222. PubMed ID: 30978501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3CA gene mutations and overexpression: implications for prognostic biomarker and therapeutic target in Chinese esophageal squamous cell carcinoma.
    Wang L; Shan L; Zhang S; Ying J; Xue L; Yuan Y; Xie Y; Lu N
    PLoS One; 2014; 9(7):e103021. PubMed ID: 25054828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIK3CA mutation status in Japanese lung cancer patients.
    Kawano O; Sasaki H; Endo K; Suzuki E; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Lung Cancer; 2006 Nov; 54(2):209-15. PubMed ID: 16930767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcriptional regulation of SOX2 on FOXA1 gene and its application in diagnosis of human breast and lung cancers.
    Li X; Chen S; Sun T; Xu Y; Chen Y; Liu Y; Xiang R; Li N
    Clin Lab; 2014; 60(6):909-18. PubMed ID: 25016694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3CA promotes proliferation and motility but is unassociated with lymph node metastasis or prognosis in esophageal squamous cell carcinoma.
    Zheng S; Yang C; Lu M; Liu Q; Liu T; Dai F; Gao X; Sheyhidin I; Lu X
    Hum Pathol; 2016 Jul; 53():121-9. PubMed ID: 27001433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy.
    Yoon HI; Park KH; Lee EJ; Keum KC; Lee CG; Kim CH; Kim YB
    Cancer Res Treat; 2016 Apr; 48(2):473-82. PubMed ID: 26323639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China.
    Song B; Cui H; Li Y; Cheng C; Yang B; Wang F; Kong P; Li H; Zhang L; Jia Z; Bi Y; Wang J; Zhou Y; Liu J; Wang J; Zhao Z; Zhang Y; Hu X; Shi R; Yang J; Liu H; Yan T; Li Y; Xu E; Qian Y; Xi Y; Guo S; Chen Y; Wang J; Li G; Liang J; Jia J; Chen X; Guo J; Wang T; Zhang Y; Li Q; Wang C; Cheng X; Zhan Q; Cui Y
    Oncotarget; 2016 Jan; 7(3):3599-613. PubMed ID: 26528858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
    Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays.
    Kenmotsu H; Serizawa M; Koh Y; Isaka M; Takahashi T; Taira T; Ono A; Maniwa T; Takahashi S; Mori K; Endo M; Abe M; Hayashi I; Nakajima T; Ohde Y; Yamamoto N
    BMC Cancer; 2014 Oct; 14():786. PubMed ID: 25348872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
    Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
    J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.
    Bayo P; Jou A; Stenzinger A; Shao C; Gross M; Jensen A; Grabe N; Mende CH; Rados PV; Debus J; Weichert W; Plinkert PK; Lichter P; Freier K; Hess J
    Mol Oncol; 2015 Oct; 9(8):1704-19. PubMed ID: 26040981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-level dissection of chromosome 3q locus amplification in squamous cell carcinoma of the lung using the nCounter assay.
    Jeon T; Oh UJ; Min J; Kim C
    Thorac Cancer; 2023 Sep; 14(26):2635-2641. PubMed ID: 37469197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.